Skip to main content

What type of drug is Steglatro?

Medically reviewed by Last updated on Feb 16, 2023.

Official answer


Steglatro (ertugliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor.

This drug is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose), which is then eliminated in the urine and lowers blood sugar.

Related medical questions

Drug information

Related support groups